(FM) Inmunología
Departamento académico
Erasmus University Medical Center
Róterdam, HolandaPublikationen in Zusammenarbeit mit Forschern von Erasmus University Medical Center (1)
2024
-
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors
Clinical Cancer Research, Vol. 30, Núm. 13, pp. 2693-2701